Several possible studies
Story checked
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium (opens in a new tab)
news-medical.net · 2026-10-05
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
news-medical.net · 2026-10-05
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedCN Bio announced the full scientific program for the 2026 'From Insight to Decision' e-Symposium, to be held on December 2 and 8.View evidenceHide evidence
As stated2026; December 2 and 8
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip use within existing R&D strategies.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedThe program will cover organ-on-a-chip fundamentals, model development, ADME/DMPK, and toxicology, along with panel discussions, presentations, peer case studies, and Q&As from organ-on-a-chip leaders.View evidenceHide evidence
As statedfour distinct sessions
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedCN Bio says the symposium was created in response to legislative and regulatory changes and to help researchers with questions about adopting organ-on-a-chip technologies.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedThe company says organ-on-a-chip models can provide mechanistic insights that support more confident pre-clinical research decision-making.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
AI-integrated human-relevant alternatives to animal experimentation in drug development: Toward a predictive translational ecosystem, from in vitro and in silico models to clinical and real-world evidence.
Alternatives to Laboratory Animals : ATLA · 2026 · PubMed, Europe PMC
Harnessing the power of microphysiological systems for COVID-19 research
Drug Discovery Today · 2021 · Crossref
Applications of in vitro transporter assays for mechanistic characterization and prediction of clinical drug-drug interactions.
Drug Metabolism and Pharmacokinetics · 2026 · PubMed
Development of MPS (Microphysiological Systems) and its application in drug discovery
Drug Delivery System · 2025 · Crossref
Introduction to the 3RsC's cross-platform microphysiological systems evaluation for drug-induced liver injury in collaboration with FDA-CDER.
2026 · Europe PMC
And 10 more candidates considered.